Revised. Amendments from Version 1
==================================

We have revised the article and expanded the methods section in response to comments from reviewers (Hans Lund and Mona Nasser).

Introduction
============

In 2014, in response to concerns about avoidable waste in research prioritization, conduct, and reporting ^[@ref-1]^, *The Lancet* published a series of articles which identified specific recommendations for the biomedical research community to ensure value and minimize inefficiency in research ^[@ref-2]--\ [@ref-6]^. Research funders were a major target for these recommendations, along with regulators, journals, academic institutions and researchers themselves. Prompted by these and related activities, the biomedical research community around the world has begun considering best practices to ensure value in publicly-funded research. As key contributors ^[@ref-7]^, research funders are encouraged to audit and update their own policies and practice, even as external assessments of funders are also undertaken ^[@ref-8],\ [@ref-9]^.

In light of these trends, the Patient-Centered Outcomes Research Institute (PCORI), undertook an organizational case study of its policies and practices. PCORI was created in 2010 to address research needs of a range of healthcare stakeholders through clinical comparative effectiveness research, and ranks among the top 10 US non-commercial funders of health research (see [Healthresearchfunders.org](http://www.healthresearchfunders.org/health-research-funding-organizations/)). Our goals were to examine and report how closely PCORI adheres to best practice recommendations for research funders (i.e., to foster transparency), to highlight areas of needed development for PCORI (to foster public accountability), and to consider how other research funders in the US and elsewhere can examine, report, and adopt best practices for supporting value in research (to foster enterprise-wide efficiency).

Methods
=======

To maximize comparability, we adapted another funder's self-assessment methods (M. Westmore, personal communication, June 15, 2016; See [Adding Value in Research from the National Institute for Health Research](https://www.nihr.ac.uk/about-us/who-we-are/our-policies/adding-value-in-research.htm)). PCORI staff (KD, LF, EW) examined PCORI's existing policies and initiatives against 17 recommendations for funding agencies from the *Lancet* series ^[@ref-2]--\ [@ref-6]^; after initial assessment, we consulted with additional PCORI staff members to confirm accurate interpretation of policies and processes (see [PCORI site](https://www.pcori.org/)). Many of the 17 *Lancet* recommendations include multiple components. To accurately assess and transparently communicate our performance across all intended components of these recommendations, we subdivided some recommendations to capture each dimension within them separately, for a total of 35 sub-recommendations. ( [Table 1](#T1){ref-type="table"}). Four authors (KD, LF, EW, GN) independently categorized fidelity to the 17 recommendations as: 1) "area of strength" --PCORI's practices reasonably address all sub-recommendations; 2) "area of partial strength" --PCORI's practices reasonably or partially address all sub-recommendations; 3) "area of growth" --PCORI's practices do not address all sub-recommendations, either reasonably or partially; or 4) not applicable. We resolved discrepancies through discussion and final ratings reflect consensus.

Results
=======

[Table 1](#T1){ref-type="table"} represents a detailed summary (through November 2018) of PCORI's policies and practices related to ensuring value in research. Across the 17 recommendations (35 sub-recommendations), two recommendations were not applicable (1, 8), and one recommendation primarily applies to non-funders (both 9a, 9b). For the 15 relevant recommendations, PCORI at least partially addresses most of the relevant sub-recommendations (28/33). Our consensus process categorized PCORI's existing policies and practices as "areas of strength" for 6/15 applicable recommendations, "partial strength" for 3/15. PCORI's authorizing legislation, although preceding the Lancet recommendations by several years, mandated a number of these (indicated in bold in the table).

###### Assessment of PCORI's policies and practices related to ensuring value in research.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  LANCET SERIES RECOMMENDATIONS                                                               RELATED PROCESSES OR INITIATIVES AT PATIENT-CENTERED\                      SELF-ASSESSMENT
                                                                                              OUTCOMES RESEARCH INSTITUTE (PCORI)                                        
  ------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- --------------------------
  1.  More investigations into research should be done to identify factors associated with\     •   Not applicable - **PCORI is authorized to fund comparative**\        Not applicable
  successful replication of basic research and translation to application in health care,\    **clinical effectiveness research with direct application to**\            
  and how to achieve the most productive ratio of basic to applied research                   **health care decision making**.                                           

  2.  Research funders should make information available about how decisions are\             **  •   PCORI's multi-stakeholder Board of Governors meetings are**\       Area of strength
  made about what research to support (2a) and fund investigations into the effects of\       **conducted in an open forum, allowing members of the public**\            
  initiatives to engage potential users of research in research prioritization (2b)           **to listen and provide comment on the proceedings.** (2a)\                
                                                                                                •   PCORI incorporates potential users of research throughout\           
                                                                                              the decision-making process from identification of research\               
                                                                                              priorities to topic refinement, in review of applications for\             
                                                                                              research funding. PCORI publishes criteria and processes\                  
                                                                                              guiding the topic pathway which determines focused research\               
                                                                                              funding opportunities. (2a)\                                               
                                                                                                •   PCORI's Engagement Awards provide funding for patient and\           
                                                                                              stakeholder groups for prioritization of research topics. (2b)\            
                                                                                                •   PCORI has funded studies focused on improving the methods\           
                                                                                              for research prioritization. (2b)                                          

  3.  Research funders and regulators should demand that proposals for additional\              •   PCORI's Methodology Standards require that any proposed\             Area of partial strength
  primary research are justified by systematic reviews (3a), showing what is already\         study be justified by evidence gaps identified through gap\                
  known (3b), and increase funding for the syntheses of existing evidence (3c)                analysis or systematic review. (3a)\                                       
                                                                                                •   The first of the PCORI application Merit Review Criteria requires\   
                                                                                              that applications demonstrate the potential for the study to fill\         
                                                                                              critical gaps in evidence. (3a; 3b)\                                       
                                                                                                •    **PCORI's legislation specifies its use of evidence synthesis**\    
                                                                                              **to increase quality and relevance of information;** programs\            
                                                                                              for funding evidence syntheses have been expanding since\                  
                                                                                              2016 including systematic reviews and updates, individual\                 
                                                                                              patient data meta-analysis and other evidence synthesis\                   
                                                                                              approaches. (3c)\                                                          
                                                                                                •   PCORI has funded studies on improving methods for systematic\        
                                                                                              reviews. (3c)                                                              

  4.  Research funders and research regulators should strengthen and develop sources\           •   Abstracts and project statuses for all research awards are\          Area of growth
  of information about in progress research (4a), ensure that this information is used\       available on PCORI's website with links to project registration in\        
  by researchers (4b), insist on publication of protocols at study inception (4c), and\       clinicaltrials.gov, PROSPERO, and Registry of Patient Registries\          
  encourage collaboration to reduce waste (4d)                                                (RoPR). (4a)\                                                              
                                                                                                •   PCORI launched several topic-based, multi-stakeholder\               
                                                                                              networks to increase cross-learning, information sharing,\                 
                                                                                              collaboration, and uptake of findings. (4d)\                               
                                                                                                •   PCORI consults with other US funders when considering new\           
                                                                                              research topics and initiatives to prevent duplication and\                
                                                                                              identify areas for collaboration or co-funding. (4d)                       

  APPROPRIATE RESEARCH DESIGN, CONDUCT, AND ANALYSIS ARE EMPLOYED                                                                                                        

  5.  Make publicly available the full protocols (5a), analysis plans or sequence of\           •    **PCORI's authorizing legislation requires that research**\         Area of growth
  analytical choices (5b), and raw data (5c) for all designed and undertaken\                 **protocols, methods of research and analysis, and other**\                
  biomedical research                                                                         **information be made publicly available concurrent with the**\            
                                                                                              **release of research findings**. (5a; 5b)\                                
                                                                                                •   PCORI's policy on Replication and Reproducibility of Research\       
                                                                                              and Data Sharing requires awardees to submit the final protocol\           
                                                                                              to PCORI, requires applicants/awardees to submit a data-\                  
                                                                                              sharing plan, and permits PCORI to request data sharing and to\            
                                                                                              share protocols upon request. (5a; 5b; 5c)                                 

  6.  Maximize the effect to bias ratio in research through: defensible design and conduct\     •    **PCORI established a set of Methodology Standards for**\           Area of strength
  standards (6a), a well-trained methodological research workforce (6b), continuing\          **relevant research designs and requires that all PCORI-**\                
  professional development (6c), and involvement of non-conflicted stakeholders (6d)          **funded research adhere to relevant PCORI Methodology**\                  
                                                                                              **Standards**. (6a)\                                                       
                                                                                                •   PCORI offers training opportunities to develop the research\         
                                                                                              workforce and support researchers in understanding and\                    
                                                                                              applying the Methodology Standards, including continuing\                  
                                                                                              medical education (CME). (6b; 6c)\                                         
                                                                                                •    **PCORI's requires that any conflicts of interest be disclosed**\   
                                                                                              **for advisory panel members, individuals involved in the**\               
                                                                                              **peer-review process, Board and Methodology Committee,**\                 
                                                                                              **and for executive staff of the Institute**. PCORI's Policy on\           
                                                                                              Conflict of Interest (COI), Confidentiality, and Non-Disclosure\           
                                                                                              ensures that application merit reviewers provide objective\                
                                                                                              evaluations of applications for funding. (6d)\                             
                                                                                                •   Individual patient data meta-analyses are set up to involve third\   
                                                                                              party researchers with strict COI consideration consistent with\           
                                                                                              guidance from the Institute of Medicine and the World Health\              
                                                                                              Organization. (6d)                                                         

  7.  Reward (with funding and academic or other recognition) reproducibility practices\      Not yet developed                                                          Area of growth
  and reproducible research and enable an efficient culture for replication of research                                                                                  

  RESEARCH REGULATION AND MANAGEMENT IS EFFICIENT                                                                                                                        

  8.  People regulating research should use their influence to reduce other causes of\          •   Not applicable --PCORI does not regulate research.                   Not applicable
  waste and inefficiency in research                                                                                                                                     

  9.  Regulators and policy makers should work with researchers, patients, and health\          •   PCORI follows practices recommended by Office for Human\             Area of partial strength
  professionals to streamline and harmonize the laws, regulations, guidelines, and\           Research Protections, National Institutes of Health, and seeks\            
  processes that govern whether and how research can be done (9a), and ensure that\           counsel to harmonize human subject protections. (9a; 9b)\                  
  these factors are proportionate to the plausible risks associated with the research\          •   Accelerating Patient-Centered Outcomes Research and\                 
  (9b)                                                                                        Methodological Research is one of PCORI's five national\                   
                                                                                              priorities for research. PCORI's Methods Program is funding\               
                                                                                              research on novel approaches to improving research efficiency\             
                                                                                              in informed consent (9a; 9b)\                                              
                                                                                                •   PCORnet, the national patient-centered clinical research\            
                                                                                              network launched by PCORI, has done extensive work related\                
                                                                                              to multi-institutional contracting, IRB oversight, data sharing and\       
                                                                                              data linkage. (9a, 9b)                                                     

  10.  Researchers and research managers should increase the efficiency of recruitment\         •    **PCORI's multi-stakeholder Advisory Panel on Clinical**\           Area of partial strength
  and retention of participants, data monitoring, and data sharing in research through\       **Trials advises PCORI on the selection, research design,**\               
  the use of research designs known to reduce inefficiencies (10a), and do additional\        **implementation, and technical issues of clinical trials**\               
  research to learn how efficiency can be increased (10b)                                     **for patient-centered outcomes research.** Recruitment\                   
                                                                                              subcommittee advises on strategies for appropriate patient\                
                                                                                              recruitment, accrual and retention of participants in clinical\            
                                                                                              trials. (10a)\                                                             
                                                                                                •   PCORI launched the National Patient-Centered Clinical\               
                                                                                              Research Network (PCORnet), a collaboration involving 33\                  
                                                                                              individual partner networks, intended to conduct clinical\                 
                                                                                              research incorporating patient health information more\                    
                                                                                              efficiently and at lower cost than is currently possible; intended\        
                                                                                              efficiencies in recruitment, retention, data monitoring and data\          
                                                                                              sharing still being explored. (10b)\                                       
                                                                                                •   PCORI is funding research on novel approaches to improving\          
                                                                                              research efficiency in recruitment, appropriate use of\                    
                                                                                              observational data for valid causal inference, and methods to\             
                                                                                              allow for real-world clinical research. (10b)                              

  11.  Everyone, particularly individuals responsible for health-care systems, can help to\     •   PCORI promotes integration of research in everyday clinical\         Area of strength
  improve the efficiency of clinical research by promoting integration of research in\        practice through:\                                                         
  everyday clinical practice                                                                            •   Demonstration: 139 healthcare sites are embedded within\     
                                                                                              PCORnet sites\                                                             
                                                                                                        •   Funding: PCORI conducts many pragmatic studies in real-\     
                                                                                              world settings\                                                            
                                                                                                        •   Training: PCORI and the Agency for Healthcare Research\      
                                                                                              and Quality are co-funding workforce training within\                      
                                                                                              learning health systems.\                                                  
                                                                                                        •   Dissemination: PCORI works with stakeholders, including\     
                                                                                              healthcare systems, to promote dissemination and\                          
                                                                                              implementation of key research findings and provides\                      
                                                                                              competitive funding opportunities for these purposes.                      

  ALL RESEARCH IS REPORTED AND DATA ARE ACCESSIBLE                                                                                                                       

  12.  Institutions and funders should adopt performance metrics that recognize full\           •    **PCORI-funded research findings are required to convey**\          Area of growth
  dissemination of research (12a) and reuse of original datasets by external\                 **full results including considerations specific to certain**\             
  researchers (12b)                                                                           **subpopulations and study limitations**. (12a)\                           
                                                                                                •   PCORI's Board of Governors monitors high-level performance\          
                                                                                              metrics on dissemination of research findings. (12a)\                      
                                                                                                •   PCORI has developed initial Data Management and Data\                
                                                                                              Sharing policies but not performance measures. (12b)                       

  13.  Investigators, funders, sponsors, regulators, research ethics committees, and\           •   Awardees submit final research reports using a standard\             Area of growth
  journals should systematically develop and adopt standards for the content of study\        template designed to increase the quality and transparency\                
  protocols (13a) and full study reports (13b), and for data sharing practices (13c)          of reporting. Awardees are required to consider the PCORI\                 
                                                                                              Methodology Standards for data integrity, rigorous analyses,\              
                                                                                              and reporting and to follow international checklists for reporting\        
                                                                                              and assessing quality (e.g. CONSORT, STROBE, PRISMA).\                     
                                                                                              (13b)\                                                                     
                                                                                                •   PCORI's Policy on Data Management and Data Sharing was\              
                                                                                              approved by the PCORI Board of Governors on September\                     
                                                                                              7, 2018. The Policy was informed, in part, by a pilot project\             
                                                                                              that brought together PCORI awardees with data repository\                 
                                                                                              organizations. (13c)                                                       

  14.  Funders, sponsors, regulators, research ethics committees, journals, and\                •   PCORI requires awardees to register awards in clinicaltrials.gov,\   Area of growth
  legislators should endorse and enforce study registration policies (14a), wide\             PROSPERO, and Registry of Patient Registries (RoPR) (14a)\                 
  availability of full study information (14b), and sharing of participant-level data for\      •   PCORI's Public Access to Journal Articles policy provides\           
  all health research (14c)                                                                   funds for all projects to cover open access fees and requires all\         
                                                                                              publications to be deposited in PubMed Central (PMC) (14b)                 

  RESEARCH REPORTS ARE COMPLETE, UNBIASED, AND USABLE                                                                                                                    

  15.  Funders and research institutions must shift research regulations and rewards to\        •    **PCORI findings are required to undergo a Peer Review**\           Area of strength
  align with better and more complete reporting                                               **process assessing scientific quality and level of adherence**\           
                                                                                              **to PCORI methodology standards prior to publication**.\                  
                                                                                                •   Receipt of funds dependent on completion of contract\                
                                                                                              milestones, including registration of study on clinicaltrials.gov\         
                                                                                              and completion of final peer-reviewed report to be posted on\              
                                                                                              PCORI website.                                                             

  16.  Research funders should take responsibility for reporting infrastructure that\           •    **Lay and Clinician Abstracts that are comprehensible, useful,**\   Area of strength
  supports good reporting and archiving                                                       **fully convey findings, discuss considerations specific to**\             
                                                                                              **subpopulations, and address limitations as well as research**\           
                                                                                              **needs are required by law to be available on PCORI website**\            
                                                                                              **within 90 days of study completion**.\                                   
                                                                                                •   The PCORI website provides infrastructure for transparent\           
                                                                                              reporting. Audio files, Spanish translations, and other translation\       
                                                                                              products aid PCORI in the dissemination of research findings.              

  17.  Funders, institutions, and publishers should improve for authors and reviewers the\      •   PCORI's Peer Review process assesses scientific quality and\         Area of strength
  capability and capacity for high-quality and complete reporting                             level of adherence to PCORI methodology standards prior to\                
                                                                                              publication of research findings. Reviewers provide feedback to\           
                                                                                              study investigators to ensure complete reporting.                          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Recommendations sourced from Lancet series on ensuring value and minimizing waste in research ^[@ref-2]--\ [@ref-6]^

Bolded text indicates process or policy mandated by PCORI's authorizing legislation

Discussion
==========

Our consensus process categorized PCORI's existing policies and practices as meeting criteria for "areas of strength" or "partial strength" for many of the recommendations, and we also identified clear areas for growth. Examples of strengths include PCORI's requirements that funded research adhere to methodology standards to minimize bias and that all study results are posted on the PCORI website to enhance public access to findings. On the other hand, PCORI has not yet fully developed its policies and practices related to rewarding research replication and reproducibility (Recommendation 7). Further development of performance metrics, standardized approaches to all study-related reporting, and enforcement of key policies (Recommendations 12, 13, 14) offer other areas ripe for growth, particularly if undertaken in coordination with others across the research enterprise. PCORI like many funders, is still actively developing its practices related to publicly sharing information, including raw data, as early as possible from funded research (Recommendations 4, 5). For example, making research protocols publicly available (Recommendation 5a) is required by PCORI's authorizing legislation, but timing and format were not specified, and our current practices may not be ideal. PCORI now requires funded investigators to submit a study protocol and record its details in an appropriate registry but does not yet specify a standard protocol format nor require protocol publication before study completion. To our knowledge, just one funder (NIHR) clearly publishes study protocols at the time of award ^[@ref-10]^. Nonetheless, making study protocols available at study inception can benefit the public by providing a detailed record of the planned study, which may help avoid unwitting duplication of research underway and support detection of important study deviations and post-hoc changes.

There is also opportunity for improvement through further development of policies and practices related to research data sharing and re-use. While funders can require awardees to share data from funded research and trial participants are supportive of such sharing ^[@ref-11]^, many researchers remain concerned about the impact on their work ^[@ref-12]^. PCORI's policy on data sharing ^[@ref-13]^ was informed by a public comment process as well as pilot work assessing time and effort required for investigators to prepare their data for sharing and on identifying appropriate repository models. Accelerating the practice of responsible data sharing necessitates broad coordination between journals, academic institutions, and data-repository organizations, alongside consistent requirements and support from funders. PCORI plans to monitor progress in these areas and conduct an updated self-assessment in two years.

Efforts to reduce waste and increase value in research are in alignment with trials transparency ^[@ref-14]^, research integrity ^[@ref-15]^, administrative efficiency ^[@ref-16]^, and other similar initiatives. PCORI and other health research funders are in consortium to encourage further development and voluntary adherence to international best practice recommendations for research funders, ( [@ref-17]; [see Ensuring Value in Research (EVIR) website](http://www.ensuringvalueinresearch.org)). The Ensuring Value in Research Funders' Forum is exploring other initiatives, such as evaluating and sharing best practices for similar challenges that funders face, and considering what avenues exist to enhance efficiency and value in the full research agenda across funders. Beyond the consortium, greater transparency and coherence between funders and key players producing health research\-\--including journals, research institutions, sponsors, and regulators\-\--remains vital for tangible progress in our shared efforts ^[@ref-7],\ [@ref-18]^.

Limitations: Our methods are limited by self-assessment, but findings are consistent with audit results for PCORI from external assessors ^[@ref-10]^. In addition, the availability of policies or current practices represent only the first step, with actual performance measurement needed. Finally, while the Lancet series highlights areas for improvement for funders and others across the research enterprise, the impact of implementing and adhering to these recommendations on research value has yet to be demonstrated.

Data availability
=================

Underlying data
---------------

All data underlying the results are available as part of the article and no additional source data are required.

The authors thank Hal Sox, MD, for comments that greatly improved the manuscript.
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Version 1

This is a very important project and the authors have put a lot of effort to ensure a structured approach to self-evaluation of the organisation.

It would be helpful to have more details on the methods: Did all four authors go through all questions and sections, or was it divided between them with at least two people independently having seen each section?Did individuals respond to the question based on their experience or knowledge, or did it additionally involve any review of policies and documents internally by them?I was not sure what you meant by "reasonably" -- did you mean that PCORI has generally met the recommendation, even if there is room for improvement available (unlike "area of growth" which is a gap and needs improvement).The table provides a very good summary but in some cases like area 4 and 12, it isn't clear where the areas of growth are, so would be helpful to explain it (which is the part I mentioned is missing from the data to be able to reproduce).
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We greatly appreciate the reviewer\'s questions and suggestions. We made several revisions to the article in response to the comments.

At least two PCORI staff members reviewed each recommendation. Policies and documents were reviewed, where applicable, in addition to knowledge-based documentation. Our assessments were confirmed by other staff who were not involved as co-authors, particularly for policies and procedures not centrally documented. 

We appreciate the reviewer\'s question about the meaning of \"reasonably.\" We employed the term \"reasonably\" to indicate two things. First, that PCORI has generally met the recommendation. Second, that any assessment made relies on a qualitative judgement, but one that we sought to measure against a standard of reasonableness, i.e., \"reasonable people would come to the same conclusion looking at the same information.\" Thank you for this question, which allows us to provide this further clarification. 

We appreciate the request to be explicit, and made an effort to do so with examples in the text for areas like making the protocol publicly available (Recommendation 5a) and data sharing (Recommendations 12-14). We are limited in our ability to be completely explicit across all areas of growth for several reasons: 1) in some areas, such as ensuring the complete availability and sharing of primary study data, practices for funders and other actors are less established and more developmental than in other domains. We don\'t have clear standards against which to assign specific areas of growth; and 2) some areas of growth require strategic decisions and direction by governing bodies, once identified. For these areas,  we cannot articulate next steps without a more deliberative process which this audit and resultant activities should help stimulate. 

Thanks again for the thoughtful critique; your comments have greatly improved the article.
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Version 1

The study is a report of a self-audit done by one of the top 10 non-commercial funders in USA. The aim was to evaluate to what degree the funding agency follow international recommendations to improve the value of research investments.

This self-audit is very important for a general audience as: Researchers can understand the context and environment of funding and the reason for the requirements related to application for fundingOther funding agencies can see how to change their policies in order to improve the value of research investmentsReaders will understand the challenges related to improve the value of research investments The report should include a date for when to expect an update of the self-audit. An update - for example 2 to 3 years from now - would show the improvements and identify the biggest challenges related to improve the value of research investments.

The method is only partly described as the reader is unable to see from where the 17 recommendations and 35 subrecommendations originates. None of the link leads the reader directly to the source. In addition, as the authors use another funder´s self-assessment method, the possible alterations or adjustments made in the present self-audit should be mentioned. If no alterations were done, this should also be mentioned. Using the same assessment method makes is possible to compare, and this could have been mentioned in the Discussion.

There is an \* and a † in Table 1, I can´t find what these refers to.

In conclusion: this is a very important and useful report of a self-audit (see above), and with the minor adjustments mentioned is should be published the sooner the better.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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PCORI, USA
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We greatly appreciate the reviewer\'s comments and suggestions. 

While we routinely monitor PCORI practice, we plan to conduct a second self-assessment in two years. We added this information to the discussion section.

We appreciate the reviewer\'s suggestion regarding the methods section. In the revised article, we explicitly linked to the 17 recommendations from the *Lancet*series. We  made clearer in the text that we broke these into a total of 35 sub-recommendations, since the original 17 sometimes included multiple items against which it would have been difficult to assess and transparently communicate our current activities. In other words, it would have been easy to claim credit for doing one part of a recommendation when we were not addressing another aspect of the recommendation at all. 

The other funder\'s self-assessment was not published, so it cannot be linked to directly. We added a reference to personal communication in the revised article. We did not have a copy of their written methods so cannot make the clear comparison that is requested, but have made our approach more transparent to avoid confusion.

Thank you for pointing out the miscellaneous symbols in the table. These were holdovers from a previous version of the table and have been removed. 

Thank you for the thoughtful critique. Your comments and questions have helped us to clarify the methods used and greatly improved the article.

[^1]: **Competing interests:**Because we are employees of PCORI and this is a self-audit, it could be perceived as potentially biased. We utilized the methods used by a separate funding agency (NIHR) for a similar exercise to the extent possible. We engaged both internal staff (for knowledge and completeness of data generation) as well as Board members (for an outside informed but more objective view when rating these). For the overall self-rating, we used several rounds of feedback after independent ratings were conducted to come to a consensus. We have acknowledged this as a self-audit and that potential limitation, while also promoting the transparency and accountability it represents for a funding agency. The authors have no other relationships, circumstances, or financial activities to disclose.
